An ENU mutagenesis approach to dissect "self"-induced immune responses: Unraveling the genetic footprint of immunosurveillance

OncoImmunology

Volumn 1, Issue 6, 2012, Pages 856-862

  Cashman, Siobhan ^a   Lampe, Kristin ^a   Sheridan, Rachel ^b   Hoebe, Kasper ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

CD244; CD8+ T cells; ENU mutagenesis; Immunosurveillance; Melanoma; Missing self; NK cells

Indexed keywords

BETA 2 MICROGLOBULIN; CANCER VACCINE; CD244 ANTIGEN; ETHYLNITROSOUREA; UNCLASSIFIED DRUG;

ACE GENE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CD8+ T LYMPHOCYTE; CELL DEATH; CHIP GENE; CONTROLLED STUDY; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GERM LINE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSURVEILLANCE; IN VIVO STUDY; MALE; MELANOMA CELL; MISSENSE MUTATION; MOUSE; MUTAGENESIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SELF INDUCED IMMUNE RESPONSE; TUMOR IMMUNITY;

EID: 84886945600     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.20580     Document Type: Article

References (41)

1. Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest 2007; 117:1137-46; PMID:17476343; http://dx.doi.org/10.1172/JCI31405.
2. Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007; 450:903- 7; PMID:18026089; http://dx.doi.org/10.1038/nature06309.
3. Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 2012; 482:400-4; PMID:22318521; http://dx.doi.org/10.1038/nature10755.
4. Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. AdvImmunol 2006; 90:1-50; PMID:16730260; http://dx.doi.org/10.1016/S0065-2776(06)90001-7.
5. Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319:675-8; PMID:3951539; http://dx.doi.org/10.1038/319675a0.
6. Orr MT, Lanier LL. Natural killer cell education and tolerance. Cell 2010; 142:847-56; PMID:20850008; http://dx.doi.org/10.1016/j.cell.2010.08.031.
7. Gasser S, Raulet D. The DNA damage response, immunity and cancer. Semin Cancer Biol 2006; 16:344-7; PMID:16914325; http://dx.doi.org/10.1016/j.semcancer.2006.07.004.
8. Jaeger BN, Vivier E. Natural killer cell tolerance: control by self or self-control? Cold Spring Harb Perspect Biol 2012; 4:4; PMID:22383753; http://dx.doi.org/10.1101/cshperspect.a007229.
9. Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol 2006; 18:145-50; PMID:16740393; http://dx.doi.org/10.1016/j.smim.2006.03.003.
10. Ljunggren HG, Kärre K. In search of the 'missing self ': MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-44; PMID:2201309; http://dx.doi.org/10.1016/0167-5699(90)90097-S.
11. Dimasi N, Biassoni R. Structural and functional aspects of the Ly49 natural killer cell receptors. Immunol Cell Biol 2005; 83:1-8; PMID:15661035; http://dx.doi.org/10.1111/j.1440-711.2004.01301.x.
12. Ljunggren HG, Kärre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985; 162:1745-59; PMID:3877776; http://dx.doi.org/10.1084/jem.162.6.1745.
13. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235:267-85; PMID:20536569.
14. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9:495-502; PMID:18425106; http://dx.doi.org/10.1038/ni1581.
15. Krebs P, Barnes MJ, Lampe K, Whitley K, Bahjat KS, Beutler B, et al. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood 2009; 113:6593-602; PMID:19406986; http://dx.doi.org/10.1182/blood-2009-01-201467.
16. Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, et al. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 2006; 24:787-99; PMID:16782034; http://dx.doi.org/10.1016/j.immuni.2006.03.024.
17. Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res 2008; 68:4026-30; PMID:18519658; http://dx.doi.org/10.1158/0008-5472.CAN-08-0427.
18. Chaput N, De Botton S, Obeid M, Apetoh L, Ghiringhelli F, Panaretakis T, et al. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference. J Mol Med (Berl) 2007; 85:1069-76; PMID:17891368; http://dx.doi.org/10.1007/s00109-007-0214-1.
19. Fidler IJ. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 1975; 35:218-24; PMID:1109790.
20. Chiang EY, Henson M, Stroynowski I. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokineactivated killer cell-mediated cytolysis. J Immunol 2002; 168:2200-11; PMID:11859106.
21. Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res 2001; 61:1095-9; PMID:11221838.
22. Vaidya SV, Stepp SE, McNerney ME, Lee JK, Bennett M, Lee KM, et al. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J Immunol 2005; 174:800-7; PMID:15634901.
23. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006; 107:159-66; PMID:16150947; http://dx.doi.org/10.1182/blood-2005-04-1351.
24. Sivori S, Parolini S, Falco M, Marcenaro E, Biassoni R, Bottino C, et al. 2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol2000; 30:787-93; PMID:10741393; http://dx.doi.org/10.1002/1521-4141(200003)30:3<787::AIDIMMU787>3.0.CO;2-I.
25. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993; 151:60-70; PMID:8326140.
26. Mathew PA, Garni-Wagner BA, Land K, Takashima A, Stoneman E, Bennett M, et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 1993; 151:5328-37; PMID:8228228.
27. Schatzle JD, Sheu S, Stepp SE, Mathew PA, Bennett M, Kumar V. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc Natl Acad Sci USA 1999; 96:3870- 5; PMID:10097130; http://dx.doi.org/10.1073/pnas.96.7.3870.
28. Veillette A, Dong Z, Latour S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 2007; 27:698-710; PMID:18031694; http://dx.doi.org/10.1016/j.immuni.2007.11.005.
29. Cocks BG, Chang CC, Carballido JM, Yssel H, deVries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995; 376:260-3; PMID:7617038; http://dx.doi.org/10.1038/376260a0.
30. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998; 395:462-9; PMID:9774102; http://dx.doi.org/10.1038/26683.
31. Roncagalli R, Taylor JE, Zhang S, Shi X, Chen R, Cruz-Munoz ME, et al. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat Immunol 2005; 6:1002-10; PMID:16127454; http://dx.doi.org/10.1038/ni1242.
32. Bloch-Queyrat C, Fondanèche MC, Chen R, Yin L, Relouzat F, Veillette A, et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J Exp Med 2005; 202:181-92; PMID:15998796; http://dx.doi.org/10.1084/jem.20050449.
33. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005; 105:4722-9; PMID:15713798; http://dx.doi.org/10.1182/blood-2004-09-3796.
34. Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000; 192:337-46; PMID:10934222; http://dx.doi.org/10.1084/jem.192.3.337.
35. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 1999; 162:6981-5; PMID:10358138.
36. Watzl C, Stebbins CC, Long EO. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J Immunol 2000; 165:3545-8; PMID:11034353.
37. Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012; 335:344-8; PMID:22267813; http://dx.doi.org/10.1126/science.1215621.
38. Beutler B, Du X, Xia Y. Precis on forward genetics in mice. Nat Immunol 2007; 8:659-64; PMID:17579639; http://dx.doi.org/10.1038/ni0707-659.
39. Hoebe K. Genetic dissection of Toll-like receptor signaling using ENU mutagenesis. Methods Mol Biol 2009; 517:239-51; PMID:19378030; http://dx.doi.org/10.1007/978-1-59745-541-1_15.
40. Barker DL, Hansen MS, Faruqi AF, Giannola D, Irsula OR, Lasken RS, et al. Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res 2004; 14:901- 7; PMID:15123587; http://dx.doi.org/10.1101/gr.1949704.
41. Sheridan R, Lampe K, Shanmukhappa SK, Putnam P, Keddache M, Divanovic S, et al. Lampe1: an ENUgermline mutation causing spontaneous hepatosteatosis identified through targeted exon-enrichment and nextgeneration sequencing. PLoS One 2011; 6:21979; PMID:21760938; http://dx.doi.org/10.1371/journal.pone.0021979.